DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Teduglutide

Teduglutide

  • The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands

    The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands

  • Teduglutide

    Teduglutide

  • Gattex Teduglutide Rdna Origin

    Gattex Teduglutide Rdna Origin

  • Teduglutide for Treating Short Bowel Syndrome

    Teduglutide for Treating Short Bowel Syndrome

  • Membrane-Tethered Ligands Are Effective Probes for Exploring Class B1 G Protein-Coupled Receptor Function

    Membrane-Tethered Ligands Are Effective Probes for Exploring Class B1 G Protein-Coupled Receptor Function

  • WO 2018/142363 Al 09 August 2018 (09.08.2018) W !P O PCT

    WO 2018/142363 Al 09 August 2018 (09.08.2018) W !P O PCT

  • Identification and Characterization of the Glucagon- Like Peptide-2 Hormonal System in Ruminants

    Identification and Characterization of the Glucagon- Like Peptide-2 Hormonal System in Ruminants

  • WO 2019/069274 Al 11 April 2019 (11.04.2019) W 1P O PCT

    WO 2019/069274 Al 11 April 2019 (11.04.2019) W 1P O PCT

  • ADOCIA Corporate Presentation

    ADOCIA Corporate Presentation

  • Presentation of Several Zealand Peptide Therapeutics at the Th American Diabetes Association’S (ADA) 74 Scientific Sessions

    Presentation of Several Zealand Peptide Therapeutics at the Th American Diabetes Association’S (ADA) 74 Scientific Sessions

  • BCBSM Clinical Drug List (Formulary)

    BCBSM Clinical Drug List (Formulary)

  • GATTEX (Teduglutide) RATIONALE for INCLUSION in PA PROGRAM

    GATTEX (Teduglutide) RATIONALE for INCLUSION in PA PROGRAM

  • Press Release

    Press Release

  • Lists of Medicinal Products for Rare Diseases in Europe*

    Lists of Medicinal Products for Rare Diseases in Europe*

  • Annual Report 2016

    Annual Report 2016

  • Injectable Medication Hcpcs/Dofr Crosswalk

    Injectable Medication Hcpcs/Dofr Crosswalk

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Glucagon-Like Peptide-1 Receptor Agonists Are Not Associated with Retinal Adverse Events in the FDA Adverse Event Reporting System

    Glucagon-Like Peptide-1 Receptor Agonists Are Not Associated with Retinal Adverse Events in the FDA Adverse Event Reporting System

Top View
  • Guidance for Industry- Synthetic Peptides
  • Towards a Peptide Implant : Analytics , Dry Heat Behavior and Functional Characterization
  • Quantum of Effectiveness Evidence in FDA's Approval of Orphan Drugs
  • Self-Administered Specialty Drug List
  • Discovery, Characterization, and Clinical Development of the Glucagon-Like Peptides
  • Minutes of PRAC Meeting on 12-15 March 2019 for Publication
  • Specialty Formulary
  • Eappendix Table 1. Drug Classifications I
  • Teduglutide (Gattex )
  • Press Release
  • Press Release
  • Zp7570: a Novel Glp-1/Glp-2 Dual Acting Peptide with Potential As The
  • Reimbursement Criteria for Frequently Requested Drugs
  • The Effects of Ph and Excipients on Exenatide Stability in Solution
  • NH Medicaid Top 25 Drugs by Cost Page 1 of 5 MAC 09/18/18 State
  • Bindex 559..578
  • GLP-1 and Intestinal Diseases
  • Teduglutide (Gattex®) Increases Small Intestinal Mass in Preclinical Study • 39 Amino Acids • 33 Amino Acids


© 2024 Docslib.org    Feedback